Topical Medications for Nighttime Neuropathy of the Toes

First-Line Topical Treatment

The American Diabetes Association recommends lidocaine 5% patches for nocturnal neuropathic foot pain, applied to the affected toes/feet for up to 12 hours before sleep, with limited data and no effectiveness for more widespread pain distribution 1
Up to 3 patches may be worn on the dorsal or plantar surface of the feet, delivering lidocaine gradually over hours for sustained nighttime relief 2
Over-the-counter 4% lidocaine patches are available, though prescription 5% strength may be more effective, with no systemic absorption or lidocaine toxicity reported with proper use 2

The American Diabetes Association notes that capsaicin can be considered if lidocaine patches are ineffective or contraindicated, requiring consistent daytime application rather than nighttime-only use 1
The 8% capsaicin patch is FDA-approved for diabetic peripheral neuropathy, providing the strongest evidence for efficacy, applied for 30-60 minutes under medical supervision with effects lasting up to 90 days 1, 3
Low-concentration capsaicin cream (0.075%) should be applied 3-4 times daily for at least 6-8 weeks to assess efficacy, with initial burning sensation typically resolving with continued use 1, 3

Amitriptyline 1-2% with ketamine 0.5-5% cream can be applied up to 3 times daily, blocking sodium channels and antagonizing N-methyl-D-aspartate receptors, with 75% of patients with erythromelalgia noting improvement in case series 2

Any topical treatment should be tried for at least 4 weeks before switching to assess true efficacy, with patients with more severe and longer duration of disease tend to respond less well to topical treatments 2, 3
Local skin reactions (burning, erythema) are common with capsaicin but usually tolerable and attenuate with time, with the number needed to harm being 2.5 1, 3
Topical treatments are best suited for localized neuropathic pain and for patients with contraindications to oral pharmacotherapy or who prefer topical treatments, causing fewer systemic adverse effects compared to oral medications 1, 2, 3